Abstract
We have coined the term “Malignant Obesity Hypoventilation Syndrome” (MOHS) to describe a severe multisystem disease due to the systemic effects of obesity. Patients with this syndrome have severe obesity related hypoventilation together with systemic hypertension, diabetes and the metabolic syndrome, left ventricular hypertrophy with diastolic dysfunction, pulmonary hypertension and hepatic dysfunction. Patients with MOHS are frequently admitted to the ICU with hypercapnic respiratory failure and have a high mortality. This syndrome is largely unrecognized as physicians do not make the association between the patients’ multiple medical problems and obesity. Due to the delayed diagnosis and progressive morbidities of this condition all patients with a BMI > 40 kg/m2 should be screened for MOHS. The management of patients with MOHS includes short term measures to improve the patients’ medical condition and long term measures to achieve enduring weight loss. Bariatric surgery reverses or improves the multiple metabolic and organ dysfunctions associated with MOHS and should be strongly considered in these patients.
Keywords: Diabetes, diastolic heart failure, metabolic syndrome, myocardial hypotrophy, non-acholic steato-hepatitis, obesity, obesity hypoventilation syndrome, pulmonary hypertension.
Current Respiratory Medicine Reviews
Title:The Malignant Obesity Hypoventilation Syndrome (MOHS)
Volume: 10 Issue: 4
Author(s): Paul E. Marik and Joseph Varon
Affiliation:
Keywords: Diabetes, diastolic heart failure, metabolic syndrome, myocardial hypotrophy, non-acholic steato-hepatitis, obesity, obesity hypoventilation syndrome, pulmonary hypertension.
Abstract: We have coined the term “Malignant Obesity Hypoventilation Syndrome” (MOHS) to describe a severe multisystem disease due to the systemic effects of obesity. Patients with this syndrome have severe obesity related hypoventilation together with systemic hypertension, diabetes and the metabolic syndrome, left ventricular hypertrophy with diastolic dysfunction, pulmonary hypertension and hepatic dysfunction. Patients with MOHS are frequently admitted to the ICU with hypercapnic respiratory failure and have a high mortality. This syndrome is largely unrecognized as physicians do not make the association between the patients’ multiple medical problems and obesity. Due to the delayed diagnosis and progressive morbidities of this condition all patients with a BMI > 40 kg/m2 should be screened for MOHS. The management of patients with MOHS includes short term measures to improve the patients’ medical condition and long term measures to achieve enduring weight loss. Bariatric surgery reverses or improves the multiple metabolic and organ dysfunctions associated with MOHS and should be strongly considered in these patients.
Export Options
About this article
Cite this article as:
E. Marik Paul and Varon Joseph, The Malignant Obesity Hypoventilation Syndrome (MOHS), Current Respiratory Medicine Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573398X11666150427223059
DOI https://dx.doi.org/10.2174/1573398X11666150427223059 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Right Ventricle: Biologic Insights and Response to Disease: Updated
Current Cardiology Reviews Highlighting Exosomes’ Function in Cardiovascular Diseases
Current Cardiology Reviews FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
Current Neurovascular Research The Heme Oxygenase System and Type-1 Diabetes
Current Pharmaceutical Design The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews Design, Synthesis and Biological Evaluation of Antipicornaviral Pyrrole-Containing Peptidomimetics
Protein & Peptide Letters Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress
Current Pharmaceutical Design Patent Selections
Recent Patents on Medical Imaging Meet Our Editor:
Current Cardiology Reviews Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics Endothelins Role in the Control of the Acute Phase of Trypanosoma cruzi Infection
Mini-Reviews in Medicinal Chemistry Helminth Infections and Cardiovascular Diseases: Toxocara Species is Contributing to the Disease
Current Cardiology Reviews Hydrogen Sulfide in Diabetic Complications: Focus on Molecular Mechanisms
Endocrine, Metabolic & Immune Disorders - Drug Targets New Developments in Anthracycline-Induced Cardiotoxicity
Current Medicinal Chemistry Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances
Current Clinical Pharmacology Advanced Echocardiographic Imaging of the Congenitally Malformed Heart
Current Cardiology Reviews Current Pharmacological Approach to Restore Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry A Comprehensive Review of Pharmacokinetics and Pharmacodynamics in Animals: Exploration of Interaction with Antibiotics of Shuang-Huang- Lian Preparations
Current Topics in Medicinal Chemistry Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease
Current Medicinal Chemistry